Recalls & Warnings November 25, 2017 Seller of "BounceBack" Joint Supplement and Others Products Warned for Drug Claims On November 14, 2017, the FDA sent a warning letter to Mannatech Incorporated following a facility inspection that found the products BounceBack, MannaBears, ImmunoSTART, TruSHAPE, and Catalyst to be in violation of the Current Good Manufacturing
For a detailed comparison of DSIP delivery forms, read DSIP Nasal Spray vs Injections: Similarities & Differences
Research suggests that astaxanthin is significantly more potent than many other common antioxidants when it comes to neutralizing singlet oxygena specific type of free radical
For context, the American Heart Association considers anything above 150 mg/dL elevated
Always consult your physician before starting a new diet or supplements